Published in Cancer Res on August 24, 2010
Combined p53-related genetic variants together with HPV infection increase oral cancer risk. Int J Cancer (2011) 0.96
Polymorphisms of MDM4 and risk of squamous cell carcinoma of the head and neck. Pharmacogenet Genomics (2011) 0.87
MicroRNA variants increase the risk of HPV-associated squamous cell carcinoma of the oropharynx in never smokers. PLoS One (2013) 0.82
Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma. Cancer Res (2013) 0.82
MDM2 T309G polymorphism and esophageal cancer risk: a meta-analysis. Int J Clin Exp Med (2015) 0.79
The Role of p53 and MDM2 in Head and Neck Cancer. ISRN Otolaryngol (2011) 0.78
Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection. Cell Cycle (2012) 0.77
MDM2 polymorphism associated with the development of cervical lesions in women infected with Human papillomavirus and using of oral contraceptives. Infect Agent Cancer (2014) 0.76
Genetic variants of NOXA and MCL1 modify the risk of HPV16-associated squamous cell carcinoma of the head and neck. BMC Cancer (2012) 0.76
Genetic variants of a BH3-only pro-apoptotic gene, PUMA, and risk of HPV16-associated squamous cell carcinoma of the head and neck. Mol Carcinog (2011) 0.75
Influence of MDM2 polymorphisms on squamous cell carcinoma susceptibility: a meta-analysis. Onco Targets Ther (2016) 0.75
Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals. Medicine (Baltimore) (2016) 0.75
Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx. Sci Rep (2017) 0.75
Association of MDM2 promoter T309G polymorphism with oral cancer risk: A meta-analysis of 3,536 subjects. Mol Clin Oncol (2016) 0.75
Effect of human papillomavirus seropositivity and E2F2 promoter variants on risk of squamous cell carcinomas of oropharynx and oral cavity. Carcinogenesis (2016) 0.75
A Functional Polymorphism (rs937283) in the MDM2 Promoter Region is Associated with Poor Prognosis of Retinoblastoma in Chinese Han Population. Sci Rep (2016) 0.75
Autofluorescence imaging in recurrent oral squamous cell carcinoma. Oral Maxillofac Surg (2015) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Surfing the p53 network. Nature (2000) 35.36
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell (1990) 20.60
Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (1992) 17.40
Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
Classification of papillomaviruses. Virology (2004) 14.16
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell (1993) 12.41
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Head and neck cancer. N Engl J Med (1993) 6.33
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28
The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol (2003) 4.46
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42
A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst (1994) 3.95
Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer (2005) 3.79
Human papillomavirus immortalization and transformation functions. Virus Res (2002) 3.58
Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (1995) 3.39
Functions of the MDM2 oncoprotein. Cell Mol Life Sci (1999) 3.35
Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature (1995) 3.32
Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol (2006) 2.91
Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer (2003) 2.69
Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer (2004) 2.59
p53: guardian of the genome and policeman of the oncogenes. Cell Cycle (2007) 2.23
Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head Neck (2007) 1.67
p53 modulation of the DNA damage response. J Cell Biochem (2007) 1.61
Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res (2002) 1.57
Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res (2003) 1.55
MDM2 promoter polymorphism SNP309 contributes to tumor susceptibility: evidence from 21 case-control studies. Cancer Epidemiol Biomarkers Prev (2007) 1.52
Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. J Natl Cancer Inst (2006) 1.51
Physical and functional interaction between p53 mutants and different isoforms of p73. J Biol Chem (2000) 1.43
High association of human papillomavirus infection with oral cancer: a case-control study. Arch Med Res (2007) 1.39
Regulation of the p53 protein by the MDM2 oncoprotein--thirty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res (1999) 1.37
MDM2 SNP309 and cancer risk: a combined analysis. Carcinogenesis (2007) 1.35
The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck. J Med Genet (2005) 1.34
Mdm-2: "big brother" of p53. J Cell Biochem (1997) 1.33
Unlocking the Mdm2-p53 loop: ubiquitin is the key. Cell Cycle (2007) 1.16
MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis. Carcinogenesis (2006) 1.11
Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6. FEBS Lett (2003) 1.03
MDM2 309T>G polymorphism and risk of lung cancer in a Korean population. Lung Cancer (2006) 1.02
Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer (2003) 0.95
MDM2 SNP309 T>G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients. Int J Cancer (2007) 0.94
Heparin in plasma samples causes nonspecific binding to histones on Western blots. J Immunol Methods (1999) 0.90
The p53-MDM2 network: from oscillations to apoptosis. J Biosci (2007) 0.90
The Mdm2 ubiquitin ligase enhances transcriptional activity of human papillomavirus E2. J Virol (2008) 0.89
MDM2 SNP309 does not confer an increased risk to oral squamous cell carcinoma but may modulate the age of disease onset. Oral Oncol (2008) 0.88
Human papillomavirus and risk of laryngeal cancer. Ann Otol Rhinol Laryngol (2000) 0.85
Expression of mdm-2 protein in neoplastic, preneoplastic, and normal bronchial mucosa specimens: comparative study with p53 expression. Hybridoma (1998) 0.78
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst (2007) 4.55
Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68
Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2009) 3.33
Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol (2009) 2.75
Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS One (2011) 2.61
DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy. J Clin Oncol (2011) 2.34
Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clin Cancer Res (2011) 2.31
Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet (2011) 2.29
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet (2011) 2.26
Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis (2008) 2.12
Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev (2003) 2.09
Teenage acne and cancer risk in US women: A prospective cohort study. Cancer (2015) 2.05
An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila) (2008) 2.05
Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. Am J Epidemiol (2009) 1.97
Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. J Natl Cancer Inst (2011) 1.97
A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res (2002) 1.87
Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies. Thyroid (2014) 1.81
Clinical correlates of NRAS and BRAF mutations in primary human melanoma. Clin Cancer Res (2010) 1.78
Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol (2013) 1.73
Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension. Head Neck (2007) 1.73
Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol (2013) 1.72
Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol (2012) 1.72
Serum cotinine concentration and wound complications in head and neck reconstruction. Plast Reconstr Surg (2008) 1.69
Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res (2005) 1.69
A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68
A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children. Pediatr Blood Cancer (2011) 1.68
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol (2009) 1.66
An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. J Natl Cancer Inst (2002) 1.65
Genomic instability and endoreduplication triggered by RAD17 deletion. Genes Dev (2003) 1.64
Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res (2004) 1.64
Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer. Radiother Oncol (2012) 1.62
Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol (2004) 1.60
Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls. Carcinogenesis (2012) 1.57
Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol (2004) 1.56
Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett (2004) 1.56
Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res (2003) 1.55
p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. J Invest Dermatol (2003) 1.54
Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis (2002) 1.52
Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev (2009) 1.51
Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Epidemiol Biomarkers Prev (2002) 1.51
Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol Carcinog (2005) 1.50
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nat Genet (2011) 1.46
Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer (2010) 1.45
Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp. Head Neck (2010) 1.44
Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer (2009) 1.43
Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma. Cancer Cytopathol (2013) 1.43
Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study. Head Neck (2008) 1.39
Polymorphisms of DNA repair genes and risk of glioma. Cancer Res (2004) 1.39
Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer (2003) 1.39
XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev (2005) 1.36
An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer (2012) 1.36
Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Int J Cancer (2009) 1.30
Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis (2007) 1.30
MUST: a system for identification of miniature inverted-repeat transposable elements and applications to Anabaena variabilis and Haloquadratum walsbyi. Gene (2009) 1.30
An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin Cancer Res (2009) 1.30
XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis (2003) 1.28
Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women. Breast Cancer Res Treat (2008) 1.28
Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res (2004) 1.27
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer. Cancer Immunol Immunother (2012) 1.27
Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat (2008) 1.26
ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis. Clin Cancer Res (2011) 1.26
Sarcomatoid carcinoma of the head and neck: molecular evidence for evolution and progression from conventional squamous cell carcinomas. Am J Surg Pathol (2003) 1.26
The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer (2009) 1.26
Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Cancer Epidemiol Biomarkers Prev (2005) 1.26
Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol (2004) 1.24
Genome-wide association studies identify several new loci associated with pigmentation traits and skin cancer risk in European Americans. Hum Mol Genet (2013) 1.23
Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. Hum Mol Genet (2011) 1.23
A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis (2011) 1.22
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol (2009) 1.22
Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum Mutat (2008) 1.22
Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2005) 1.21
Primary tracheal malignant neoplasms: the University of Texas MD Anderson Cancer Center experience. J Am Coll Surg (2005) 1.21
The Arabidopsis ATAF1, a NAC transcription factor, is a negative regulator of defense responses against necrotrophic fungal and bacterial pathogens. Mol Plant Microbe Interact (2009) 1.21
Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett (2008) 1.20
Disruption of the Rad9/Rad1/Hus1 (9-1-1) complex leads to checkpoint signaling and replication defects. Oncogene (2004) 1.20
P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett (2002) 1.20
Type of alcoholic beverage and risk of head and neck cancer--a pooled analysis within the INHANCE Consortium. Am J Epidemiol (2008) 1.19